The effect of cinnamon on polycystic ovarian syndrome
- Conditions
- Polycystic ovary syndrome.polycystic ovarian syndrome
- Registration Number
- IRCT2015121525537N1
- Lead Sponsor
- Vice chancellor for research,Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
informed consent to participate in the study? polycystic ovary syndrome diagnostic criteria Rotterdam are two of three of the following symptoms: i abnormal menstrual cycles (oligo dysmenorrhea, amenorrhea) ii polycystic ovaries on ultrasound iii clinical signs of hyperandrogenism (hirsutism -acne-) or biochemical signs of hyperandrogenism and also reject and Cushing's syndrome and congenital adrenal hyperplasia? age 45-18 years ?Body mass index (BMI) greater than or equal to 18.
Exclusion criteria:
any disease affecting variables (diabetes, liver disease, thyroid, cardiovascular, renal, gastrointestinal, Cushing's syndrome, adrenal hyperplasia, androgen-secreting tumors, hyperprolactinemia) based on the patient's previous history? Taking blood pressure medications or statins or anti-diabetic drugs and insulin injections ?Pregnancy ?Breast-feeding ?use of any vitamin supplements, minerals and hormones for at least two months before the study ?being under the special diet ?Consumers oral contraceptives (OCP), glucocorticoids, anti-androgens, ovulation induction drugs ?consumers of tobacco and alcohol ?a history of allergy to cinnamon
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight, body mass index, waist and hip. Timepoint: Before study and after 12 weeks. Method of measurement: questionnaire.;Fasting blood glucose, two hour blood glucose, serum insulin levels, lipid profile. Timepoint: Before study and after 12 weeks. Method of measurement: Blood sample.;Serum androgen levels. Timepoint: Before study and after 12 weeks. Method of measurement: Blood sample.
- Secondary Outcome Measures
Name Time Method The menstrual cycle regularity. Timepoint: Before study and after 12 weeks. Method of measurement: Questions from Patients.